These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9475605)

  • 1. Visible integration of the adenosine deaminase (ADA) gene into the recipient genome after gene therapy.
    Egashira M; Ariga T; Kawamura N; Miyoshi O; Niikawa N; Sakiyama Y
    Am J Med Genet; 1998 Jan; 75(3):314-7. PubMed ID: 9475605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo kinetics of transduced cells in peripheral T cell-directed gene therapy: role of CD8+ cells in improved immunological function in an adenosine deaminase (ADA)-SCID patient.
    Kawamura N; Ariga T; Ohtsu M; Kobayashi I; Yamada M; Tame A; Furuta H; Okano M; Egashira M; Niikawa N; Kobayashi K; Sakiyama Y
    J Immunol; 1999 Aug; 163(4):2256-61. PubMed ID: 10438969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The gene therapy for a patient with ADA deficiency; report of the first gene therapy trial in Japan].
    Ariga T; Kawamura N; Sakiyama Y
    Nihon Rinsho; 1997 Jun; 55(6):1572-9. PubMed ID: 9200950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
    Hershfield MS
    Semin Hematol; 1998 Oct; 35(4):291-8. PubMed ID: 9801258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene therapy for adenosine deaminase deficiency].
    Sakiyama Y
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):27-32. PubMed ID: 8727372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow gene therapy for adenosine deaminase deficiency.
    Kaptein LC; Einerhand MP; Braakman E; Valerio D; van Beusechem VW
    Immunodeficiency; 1993; 4(1-4):335-45. PubMed ID: 7909479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
    Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
    Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
    Taupin P
    IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: a novel form of enzyme replacement therapy for ADA deficiency.
    Carbonaro DA; Jin X; Petersen D; Wang X; Dorey F; Kil KS; Aldrich M; Blackburn MR; Kellems RE; Kohn DB
    Mol Ther; 2006 Jun; 13(6):1110-20. PubMed ID: 16651028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
    Hirschhorn R; Yang DR; Insel RA; Ballow M
    Cell Immunol; 1993 Dec; 152(2):383-93. PubMed ID: 8258146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene therapy for adenosine deaminase deficiency].
    Sakiyama Y; Ariga T; Ohtsu M
    Nihon Rinsho; 2005 Mar; 63(3):448-52. PubMed ID: 15773344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five missense mutations at the adenosine deaminase locus (ADA) detected by altered restriction fragments and their frequency in ADA--patients with severe combined immunodeficiency (ADA-SCID).
    Hirschhorn R; Ellenbogen A; Tzall S
    Am J Med Genet; 1992 Jan; 42(2):201-7. PubMed ID: 1346349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene therapy for adenosine deaminase (ADA) deficiency: review of the past, the present and the future].
    Ariga T
    Nihon Rinsho; 2001 Jan; 59(1):72-5. PubMed ID: 11197865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of the adenosine deaminase (ADA) gene of a B-lymphoblastoid cell line (LCL) to an ADA-deficient LCL by a microcell-mediated chromosome transfer technique.
    Sawami H; Ito K; Norioka M; Monden S; Fujita M; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1033-44. PubMed ID: 2588953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry.
    Sanchez JJ; Monaghan G; Børsting C; Norbury G; Morling N; Gaspar HB
    Ann Hum Genet; 2007 May; 71(Pt 3):336-47. PubMed ID: 17181544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry analysis of adenosine deaminase (ADA) expression: a simple and reliable tool for the assessment of ADA-deficient patients before and after gene therapy.
    Otsu M; Hershfield MS; Tuschong LM; Muul LM; Onodera M; Ariga T; Sakiyama Y; Candotti F
    Hum Gene Ther; 2002 Feb; 13(3):425-32. PubMed ID: 11860709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence intensity profiles of in situ hybridization signals depict genome architecture within human interphase nuclei.
    Iourov IY; Vorsanova SG; Yurov YB
    Tsitol Genet; 2008; 42(5):3-8. PubMed ID: 19140435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy of severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Cavazzana-Calvo M
    Nat Rev Immunol; 2002 Aug; 2(8):615-21. PubMed ID: 12154380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of T cell-directed gene transfer for a patient with ADA deficiency].
    Sakiyama Y; Ariga T; Kawamura N
    Nihon Rinsho; 1998 Mar; 56(3):696-700. PubMed ID: 9549359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency.
    Rogers MH; Lwin R; Fairbanks L; Gerritsen B; Gaspar HB
    J Pediatr; 2001 Jul; 139(1):44-50. PubMed ID: 11445793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.